L-arginine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on hospital length of stay
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“There was no significant difference in hospital length of stay (4.1 ± 01.8 versus 4.8 ± 2.5 days, P=0.34), although a trend favored the arginine arm, and total opioid use was strongly correlated with the duration of the admission (r=0.86, P<0.0001).”
Quoted verbatim from A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.. - Study
- RCT
- Dose
- L-arginine 100 mg/kg three times daily for 5 days or until discharge, versus placebo
- Population
- Children with sickle cell disease hospitalised with vaso-occlusive pain episodes (38 children, 56 episodes)
A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.2013PMID:23645695Permalink
Keep reading
- Everything the graph holds on L-arginine
- Every compound studied against Hospital length of stay
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PD1D6VJYJJK4XDV2116C7E